Saal Howard M, Prows Cynthia A, Guerreiro Iris, Donlin Milene, Knudson Luke, Sund Kristen L, Chang Ching-Fang, Brugmann Samantha A, Stottmann Rolf W
Division of Human Genetics.
Division of Human Genetics, Division of Patient Services.
Hum Mol Genet. 2015 Jun 15;24(12):3399-409. doi: 10.1093/hmg/ddv088. Epub 2015 Mar 10.
Autosomal dominant omodysplasia is a rare skeletal dysplasia characterized by short humeri, radial head dislocation, short first metacarpals, facial dysmorphism and genitourinary anomalies. We performed next-generation whole-exome sequencing and comparative analysis of a proband with omodysplasia, her unaffected parents and her affected daughter. We identified a de novo mutation in FRIZZLED2 (FZD2) in the proband and her daughter that was not found in unaffected family members. The FZD2 mutation (c.1644G>A) changes a tryptophan residue at amino acid 548 to a premature stop (p.Trp548*). This altered protein is still produced in vitro, but we show reduced ability of this mutant form of FZD2 to interact with its downstream target DISHEVELLED. Furthermore, expressing the mutant form of FZD2 in vitro is not able to facilitate the cellular response to canonical Wnt signaling like wild-type FZD2. We therefore conclude that the FRIZZLED2 mutation is a de novo, novel cause for autosomal dominant omodysplasia.
常染色体显性遗传的欧莫发育异常是一种罕见的骨骼发育不良,其特征为肱骨短小、桡骨头脱位、第一掌骨短小、面部畸形和泌尿生殖系统异常。我们对一名患有欧莫发育异常的先证者、其未受影响的父母以及其受影响的女儿进行了下一代全外显子组测序和比较分析。我们在该先证者及其女儿中发现了一种在未受影响的家庭成员中未发现的FRIZZLED2(FZD2)基因的新生突变。FZD2突变(c.1644G>A)将第548位氨基酸的色氨酸残基变为一个过早的终止密码子(p.Trp548*)。这种改变后的蛋白质在体外仍可产生,但我们发现这种突变形式的FZD2与其下游靶点Dishevelled相互作用的能力降低。此外,在体外表达FZD2的突变形式无法像野生型FZD2那样促进细胞对经典Wnt信号的反应。因此,我们得出结论,FZD2突变是常染色体显性遗传欧莫发育异常的一种新生的、新的病因。